Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 2,151 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Arteriosclerosis, Coronary Clear all

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Cambridge Heart Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Bridgeport, Connecticut • Tomball, Texas

Conditions: Myocardial Infarction
Interventions: Stress Challenge; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Acute Coronary Syndrome, Myocardial Infarction
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Coronary Artery Disease
Interventions: Ticagrelor 60mg, Clopidogrel; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Coronary Heart Disease, Susceptibility to, 5, Prediabetic State
Interventions: Health coaching, Genetic risk counseling, Standard risk assessment; Behavioral · Genetic
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Fairfield, California

Conditions: Coronary Heart Disease
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 625 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Coronary Artery Disease
Interventions: [3H] BMS747158; Drug
Lead sponsor: Lantheus Medical Imaging; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Atherosclerosis, Heart Diseases, Coronary, Coronary Artery Disease, Cardiovascular Diseases
Interventions: SYNERGY 4.50 mm and 5.0 mm Coronary Stent System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 9
States / cities: New Haven, Connecticut • Clearwater, Florida • Boston, Massachusetts + 6 more

Conditions: Friedreich Ataxia
Interventions: plethysmography; Diagnostic Test
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 79 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Acute Myocardial Infarction, STEMI
Interventions: TherOx DownStream System, PCI; Device
Lead sponsor: TherOx; Industry
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Decision Aid, CAD Education; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 677 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 4
States / cities: San Francisco, California • Atlanta, Georgia • Kansas City, Missouri

Conditions: Coronary Artery Disease
Interventions: ITPR; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Coronary Artery Disease
Interventions: Coronary Artery Stenting, Endeavor; Device
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Santa Rosa, California

Conditions: Coronary Artery Disease
Interventions: Cardiac SPECT imaging Rest and Stress, Caffeine; Procedure · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Coronary Artery Disease, Acute Coronary Syndrome
Interventions: BrightHeart®; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Coronary Artery Disease
Interventions: Same day discharge, Overnight Stay; Behavioral
Lead sponsor: Trinity Health Michigan; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Ypsilanti, Michigan

Conditions: Coronary Artery Disease
Interventions: Fractional Flow Reserve; Diagnostic Test
Lead sponsor: Central Arkansas Veterans Healthcare System; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 1,000 participants
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Coronary Atherosclerosis Due to Calcified Coronary Lesion
Interventions: Coronary CTA; Device
Lead sponsor: Baylor Research Institute; Other
Eligibility: 30 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease, Coronary Stenosis
Interventions: Comprehensive therapy program for risk factor modification; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 40 Years and older
Enrollment: 1,085 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Atherosclerosis, Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 40 Years to 49 Years · Male only
Enrollment: 1,027 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Stable Angina
Interventions: Ranolazine, Aerobic Exercise, Placebo; Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Artery Bypass Grafting Surgery (CABG)
Interventions: a change in operating room table position, which will mimic an IV fluid bolus; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Coronary Artery Disease
Interventions: SYNERGY 48 mm; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 8
States / cities: Birmingham, Alabama • Saint Paul, Minnesota • New York, New York + 5 more

Conditions: Acute Coronary Syndrome, Sleep Disorder
Interventions: Eszopiclone, Placebo; Drug · Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Tucson, Arizona

Search by objective public record fields.

Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia

Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis

Point of Care (POC) Biomarkers of Ischemia

Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease

Impact of Race/Ethnicity on Platelet Function

Study of [3H] BMS747158 in Healthy Male Subjects

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Coronary Artery Disease in Patients With Friedreich's Ataxia

Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.

Decisional Quality for Patients With Coronary Artery Disease

IRB-HSR# 14296 The Use of the Intrathoracic Pressure Regulator (ITPR) to Improve Systemic Blood Pressure in Patient Undergoing CABG Surgery

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?

Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease

Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge

Evaluation of the Opsens Fractional Flow Reserve (FFR) Wire as a "Work Horse" Wire

ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes

Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease

Epidemiology of Coronary Heart Disease in Men Aged 40 and Over

Effects of Ranolazine and Exercise on Daily Physical Activity Trial

SSVC-CI During CABG

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome